COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF DAILY VERSUS INTERMITTENT ANTI-TUBERCULAR MEDICATION REGIMENS IN PATIENTS WITH CATEGORY 1 TUBERCULOSIS. Int. Res. J. Pharm. 2024, 11 (9), 39-42.